Zhang Y - Search Results

1

Identification of Gem as a new candidate prognostic marker in hepatocellular carcinoma.

Huang X, Cong X, Yang D, Ji L, Liu Y, Cui X, Cai J, He S, Zhu C, Ni R, Zhang Y. Huang X, et al. Among authors: zhang y. Pathol Res Pract. 2014 Nov;210(11):719-25. doi: 10.1016/j.prp.2014.07.001. Epub 2014 Jul 17. Pathol Res Pract. 2014. PMID: 25155751

2

Expression and prognostic role of Spy1 as a novel cell cycle protein in hepatocellular carcinoma.

Ke Q, Ji J, Cheng C, Zhang Y, Lu M, Wang Y, Zhang L, Li P, Cui X, Chen L, He S, Shen A. Ke Q, et al. Among authors: zhang l, zhang y. Exp Mol Pathol. 2009 Dec;87(3):167-72. doi: 10.1016/j.yexmp.2009.07.011. Epub 2009 Aug 15. Exp Mol Pathol. 2009. PMID: 19686732

3

Double-stranded RNA-induced TLR3 activation inhibits angiogenesis and triggers apoptosis of human hepatocellular carcinoma cells.

Guo Z, Chen L, Zhu Y, Zhang Y, He S, Qin J, Tang X, Zhou J, Wei Y. Guo Z, et al. Among authors: zhang y. Oncol Rep. 2012 Feb;27(2):396-402. doi: 10.3892/or.2011.1538. Epub 2011 Nov 8. Oncol Rep. 2012. PMID: 22075935

4

[Combined three-dimensional conformal radiotherapy plus transcatheter arterial chemoembolization and surgical intervention for portal vein tumor thrombus in patients with hepatocellular carcinoma].

Wu ZJ, Cai J, Xu AB, Su XQ, Wang XQ, Zhang YX, Shao BF, Li YJ, Chu KY. Wu ZJ, et al. Zhonghua Yi Xue Za Zhi. 2011 Nov 1;91(40):2841-4. Zhonghua Yi Xue Za Zhi. 2011. PMID: 22333546 Clinical Trial. Chinese.

5

Prognostic significance of FOXP1 as an oncogene in hepatocellular carcinoma.

Zhang Y, Zhang S, Wang X, Liu J, Yang L, He S, Chen L, Huang J. Zhang Y, et al. Among authors: zhang s. J Clin Pathol. 2012 Jun;65(6):528-33. doi: 10.1136/jclinpath-2011-200547. Epub 2012 Mar 15. J Clin Pathol. 2012. PMID: 22422806

6

Expression of FOXJ1 in hepatocellular carcinoma: correlation with patients' prognosis and tumor cell proliferation.

Chen HW, Huang XD, Li HC, He S, Ni RZ, Chen CH, Peng C, Wu G, Wang GH, Wang YY, Zhao YH, Zhang YX, Shen AG, Wang HM. Chen HW, et al. Mol Carcinog. 2013 Aug;52(8):647-59. doi: 10.1002/mc.21904. Epub 2012 Apr 4. Mol Carcinog. 2013. PMID: 22488567

7

The relationship between Cyclin G1 and survival in patients treated surgically for HCC.

Cui X, Yu L, Wang Y, He S, Zhang Y, Wan C, Shi J, Jiang W, Zhang J, Mei G, Ni R. Cui X, et al. Among authors: zhang j, zhang y. Hepatogastroenterology. 2013 Jan-Feb;60(121):153-9. doi: 10.5754/hge12549. Hepatogastroenterology. 2013. PMID: 22835824

8

Glyoxylate reductase/hydroxypyruvate reductase: a novel prognostic marker for hepatocellular carcinoma patients after curative resection.

Pan Y, Ni R, Deng Q, Huang X, Zhang Y, Lu C, Li F, Huang D, He S, Chen B. Pan Y, et al. Among authors: zhang y. Pathobiology. 2013;80(3):155-62. doi: 10.1159/000346476. Epub 2013 Mar 7. Pathobiology. 2013. PMID: 23486161

9

The prognostic significance of FOXQ1 oncogene overexpression in human hepatocellular carcinoma.

Wang W, He S, Ji J, Huang J, Zhang S, Zhang Y. Wang W, et al. Among authors: zhang s, zhang y. Pathol Res Pract. 2013 Jun;209(6):353-8. doi: 10.1016/j.prp.2013.03.005. Epub 2013 Mar 25. Pathol Res Pract. 2013. PMID: 23623360

10

Increased α-tubulin1b expression indicates poor prognosis and resistance to chemotherapy in hepatocellular carcinoma.

Lu C, Zhang J, He S, Wan C, Shan A, Wang Y, Yu L, Liu G, Chen K, Shi J, Zhang Y, Ni R. Lu C, et al. Among authors: zhang j, zhang y. Dig Dis Sci. 2013 Sep;58(9):2713-20. doi: 10.1007/s10620-013-2692-z. Epub 2013 Apr 27. Dig Dis Sci. 2013. PMID: 23625295

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

262,680 results

Search Page

Filters